Tissue engineering has attracted much attention to solve the disadvantages associated with bone grafts. Bone regeneration with bone marrow stromal cells (BMSCs) requires an optimal scaffold and interconnected porous hydroxyapatite has recently been developed as a possible candidate. This study was designed to clarify a possibility of the application of a hybrid artificial bone and the results obtained may be the possible use of cell-hybridized artificial bone.
Introduction
Bone harvested from the mandible and ilium has been widely used as autogenous bone grafts in clinical situations requiring bone grafting in the oral cavity. [1] [2] [3] However, problems still exist including the limited volume of harvested bone available and complications at the donor site as a result of the necessary surgical procedure.
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To overcome these problems and to obtain predictable bone grafting, other graft materials have been developed for use as bone substitutes. Hydroxyapatite (HA) has been widely used as a graft material with excellent biocompatibility and direct bonding to repaired bone tissue. [6] [7] [8] [9] However, this direct bonding has been limited to the surface of the HA. Recently, a newly developed HA with an interconnected porous structure (IP-CHA) has been introduced and has been demonstrated to have substantial porosity. 10 Because IP-CHA has a systematic arrangement of uniform spherical interconnected pores, this material may possess qualities suitable for a graft material with osteoconduction, allowing cells to penetrate into the IP-CHA. It is well known that bone marrow stromal cells (BMSCs) contain progenitors capable of differentiation into such mesenchymal lineages as bone, cartilage, fat and connective tissue. 11, 12 Some studies have shown favorable bone formation by BMSCs on scaffolds with a coculture. 13, 14 In fact, IP-CHA has recently 15 However, there is a lack of studies using large animals. Such studies are needed to explore the possibility of a hybrid artificial bone as graft material (BMSCs/IP-CHA) using BMSCs on a scaffold of IP-CHA.
This study was, therefore, performed to clarify the possibility of bone regeneration with BMSCs/ IP-CHA composites by evaluating bone formation in the beagle dog femur.
Materials and methods

Animal
After receiving approval from the Research Facilities Committee for Laboratory Animal Science, Hiroshima University School of Medicine, one beagle dog (12 kg in weight and aged 14 months) was used in this study.
Scaffold
IP-CHA (NEOBONE ® , Toshiba ceramics Co., Tokyo, Japan) with a 75% porosity, a mean pore diameter of 150 μm and interconnective pore diameter of 40 μm (Fig. 1 ) was used as a scaffold. Both two disc-type IP-CHAs (diameter 20 mm, height 6 mm) and two cylinder-types (diameter 3.7 mm, height 7 mm) were prepared as specimens.
BMSCs har vests and culture
BMSCs were harvested by a 5 ml aspiration of iliac bone marrow from the dog. Cell culture was performed in accordance with the technique described by Tsutsumi et al. 16 BMSCs were seeded in 100 mm cell culture dishes and maintained in 10 ml of Dulbecco's modified Eagle's medium (Sigma, USA) supplemented with 10% fetal bovine serum, 0.05 unit/ml penicillin, and 0.05 mg/ml streptomycin (Gibco, USA). After three days of seeding, floating cells were removed and the medium was replaced with fresh medium. Passages were performed when cells were approaching confluence. Then, cells were seeded at 5×10 3 cells/cm 2 in 10 mm dishes and maintained in a medium containing 3 ng/ml fibroblast growth factor-2 for 2 weeks. A number of BMSCs were observed in these adherent cells. The cells were harvested with trypsin plus EDTA, washed with phosphate buffered saline, and stored in liquid nitrogen until use. In this study, cell passage 4 was used.
BMSCs labeling and sample preparation
BMSCs were labeled with the red fluorescent dye PKH-26 (Sigma, UK) before transplantation. These BMSCs were mixed with medium and 1 ml of BMSC solution (cell density 1.0×10 6 ) was injected into the IP-CHA scaffold. Through this method, both disc-type and cylinder-type BMSCs/ IP-CHA composites were fabricated with the use of disc-type and cylinder-type IP-CHA.
Scanning electron microscopy (SEM) evaluation of BMSCs/IP-CHA
Disc-type BMSCs/IP-CHA composites were examined with SEM to evaluate cell penetration into the deep pores. Twenty-four hours after injection of the BMSCs, the BMSCs/IP-CHA composites were fixed and treated for SEM observation. The sample was cut in half at the central part and this area was examined.
Animal experiment
Under general anesthesia (sodium pentobarbital, 40 mg/kg) and local infiltrated anesthesia (2% lidocaine with 1:80,000 noradrenaline), two bone sockets of 3.7 mm diameter and 7 mm depth were prepared surgically with 3.7 mm drills on the right femur of the animal for BMSCs/IP-CHA composite placement. Cylinder-type BMSCs/IP-CHA composites were placed into the bone sockets (Fig. 2) . Four weeks after surgery, the animal was sacrificed under general anesthesia, the femur was dissected, and tissue blocks containing BMSCs/IP-CHA were obtained.
One of the two tissue blocks from the right femur was fixed in 10% neutral formalin. After decalcification in hydrochloride for 5 days, the tissue block was dehydrated through graded ethanol, cleared with xylene, embedded in paraffin, cut into 5 μm thick sections with a microtome and the sections were stained with hematoxylin and eosin (H-E). The sample was examined histologically with a light microscope. The second tissue block was frozen with sucrose using dry ice with hexane and cut into the central part of the graft material. The sample was cut into 5 μ mthick sections with a cryostat microtome (Leica, Germany) at −25°C and unstained specimens were examined with fluorescent microscopy.
Results
SEM evaluation of BMSCs/IP-CHA
Injected BMSCs extended to the deep part of IP-CHA and they were visible not only on the surface of IP-CHA but also in the interconnected interior pores at the deep area. Injected BMSCs had expanded well and attached to the walls of the pores (Fig. 3) . At 3 mm below the surface, injected BMSCs were still found in the pores.
Histological evaluation of animal experiment
At 4 weeks after surgery, new bone formation was observed in the BMSCs/IP-CHA placed in the bone sockets. Newly formed bone appeared to be prominent in the cortical bone area. Most pores were filled with woven bone, lamella bone and connective tissue with vascular formation (Fig. 4) .
Fluorescent-labeled BMSCs were observed in the BMSCs/IP-CHA. Fluorescent-labeled BMSCs were identified in the interconnected pores, where new bone formation was detected (Fig. 5  a,b,c,d ). 
Discussion
The limited and preliminary results of this study suggest that injected BMSCs may promote bone regeneration in the pores of IP-CHA. It has been reported that BMSCs can be induced to differentiate into osteoblasts, chondrocytes and adipocytes and that this differentiation is affected by the environments of the surrounding tissue. [17] [18] [19] By transplanting BMSCs with an IP-CHA scaffold, promotion of tissue regeneration may be achieved. HA has been widely used as a bone substitute. Recently, HA used as a scaffold for tissue engineering has demonstrated good bone formation. [6] [7] [8] [9] However, because of inadequate pore connections in conventional HA, osteoconduction has been limited to the surface. 20 Generally speaking, over 10 μm in diameter will permit osteoconduction, 21 because the size of the nucleus in most mammalian cells is over 10 μ m. It has been reported that bone ingrowth penetrating into the HA was no more than 300 μ m from the interface at 4 months after implantation in humans. 22 In the study reported here, based on histological evaluation, the interior of the placed BMSCs/IP-CHA was filled with new bone, connective tissue and vascularization. The IP-CHA used in this study had a systematic arrangement of uniform pores, and almost all pores were interconnected. Thus, it is suggested that good osteoconduction was achieved. Furthermore, this methodology also has the advantage of the cells or growth factors being hybridized, not only on the surface but also in the IP-CHA interior. In this study, injected BMSCs were observed in the interior of the IP-CHA. The injected cells were considered to have reached the deep part of the material. Prior to this study, it could be concluded that injected cells at the interior of IP-CHA may no longer be alive because of the shortage of oxygen or nutrition supply. However, fluorescence observation demonstrated that fluorescentlabeled cells were well distributed in the broad area of IP-CHA, suggesting that the injected cells in the pores were alive. BMSCs are adhesive cells and adhere to the surface of pores if injected into IP-CHA. However, when the IP-CHA is placed within an organism, adhered cells may flow via the blood stream and outflow to other areas. In addition, the defects may be filled with bone marrow, which may mean that bone formation was achieved by BMSCs originating from the animal's own bone marrow. However, it was shown that the injected cells were widely distributed and some of them were recognized in IP-CHA as fluorescent-labeled cells. This may mean that the injected cells were at least involved in bone tissue formation in the pores. Our previous study in the laboratory showed bone formation promoted by BMSCs/IP-CHA rather than only IP-CHA at early stage of 4 weeks after placement in a beagle dog. It may be possible to use BMSCs/IP-CHA in the clinical environment, however, there is a problem of bovine serum in the cell culture medium which may be associated with the risk of bovine spongiform encephalopathy or other unknown infections. To solve this problem, a culture method using serum free medium or autologous serum may be recommended.
The findings of this limited study suggest that IP-CHA may be used to hybridize BMSCs and that injected BMSCs/IP-CHA could enhance bone regeneration. It is anticipated that further study will more fully clarify the acceleration of bone regeneration with the use of osteogenic differentiated BMSCs-hybridized artificial bone with an IP-CHA scaffold.
